Darroch Medical Solutions, Inc

MediciNova is a publicly traded biopharmaceutical company focused on acquiring and developing novel small-molecule therapeutics for the treatment of diseases with unmet need with a specific focus on the United States market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which it believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. The company s pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancer, generalized anxiety disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. Its current strategy is to focus its resources on the development and commercialization of two prioritized assets in its development pipeline, MN-221 for the treatment of status asthmaticus and MN-166 for the treatment of multiple sclerosis. MediciNova maintains a location in San Diego, Calif.

The La Jolla Institute for Immunology is a leading research organization dedicated to unraveling the complexities of the immune system to tackle a diverse array of diseases, including cancer, autoimmune conditions, and infectious diseases. With a focus on innovative research, the institute is home to several specialized centers that collaborate to accelerate the development of new treatments and vaccines. Generated from the website

Avexegen Therapeutics, Inc. is a cutting-edge medical laboratory located in San Diego, CA. Specializing in innovative therapeutic solutions, the lab focuses on developing advanced treatments to improve patient outcomes. With a dedicated team of scientists and researchers, Avexegen is committed to pushing the boundaries of medical science to address unmet healthcare needs. Generated from this place's information